Businesses For Sale

Images
NYE-Health-image-04042025-785x600.png

Nye Health Limited

Download Information 

SIA Group are excited to present the opportunity to acquire the intellectual property assets of Nye Health Limited, a platform to facilitate collection of data to improve patient health outcomes.

Incorporated in 2019, Nye Health has developed a B2B2C white-label platform offering a suite of patient-facing tools to facilitate data capture for clients across the pharmaceutical, life science and healthcare sectors, without the significant cost and time required to develop bespoke apps for this purpose.

Capturing real world data from a range of sources including surveys, medical records and newer technologies including face scanning, the platform analyses and processes the data into actionable insights for clients and patients.

The platform has a broad range of use cases including bespoke research initiatives and clinical drug trials, and Nye Health has previously partnered with Roche to combine patient data from a variety of sources including wearables to provide a comprehensive overview of patient health over a period of time.

Technology Features
- Customisable patient-facing web app that is configurable specific projects
- Patient platform used to facilitate content delivery and schedule data collection
- Segregated platform used to validate and analyse data, with insights provided using the report generation tool
- Creation and publication of personalised surveys via user friendly interface and use of advanced logic
- Robust data security and storage to handle sensitive information including medical records

Assets For Sale
- Proven software platform
- Organisational knowledge
- Registered trade mark
- Other brand related assets including domain portfolio

Interested parties are requested to deal specifically with Emre Turan at SIA Group. Further information including access to a virtual data room can be provided upon execution of an NDA. It is intended that a sale will be executed at the earliest opportunity and all expressions of interest must be registered by no later than Thursday 1st May 2025 at 12pm (BST).

Request further information

Your Name (required)

Your Email (required)

Subject

Your Message

Location